If you are Neutropenic, you may wish to discuss these new findings with your doctor.
Patients receiving therapy for haematological malignancies have a higher risk of invasive fungal infections (IFIs). Antifungal prophylaxis is an effective strategy against IFIs.
The study found that ...
Antifungal prophylaxis was more effective than no prophylaxis/placebo in reducing IFI risk.
Posaconazole was also found to be more effective than no prophylaxis/placebo in reducing all-cause mortality. The drug had the highest probability of being the most effective agent in reducing IFI risk and all-cause mortality.
The researchers say the results are consistent with the recommendations made in previous studies. In fact, the order of antifungal preference "matches that recommended in a recent study of the German Society for Haematology and Oncology."
Article Medscape ... free to join...